A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors
International Journal of Neuropsychopharmacology · 2025
DOI: 10.1093/ijnp/pyae064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Yang Miao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China. Hauptthemen laut MEDLINE: Cannabidiol, Antidepressive Agents, Depression, Receptors, Cannabinoid. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Depression is a prevalent and disabling disorder that poses serious problems in mental health care, and rapid antidepressants are novel treatments for this disorder. Cannabidiol (CBD), a nonintoxicating phytocannabinoid, is thought to have therapeutic potential due to its important neurological and anti-inflammatory properties. Despite major advances in pharmacotherapy in experimental animals, the exact mechanism of antidepressant-like effects remains to be elucidated.
Methods
In this paper, we review the current state of knowledge on the antidepressant properties of CBD in numerous experimental and clinical studies.
Results
Accumulating evidence suggests that CBD has antidepressant properties in humans and animals with few side effects, suggesting that CBD may be a potential antidepressant. Furthermore, we discuss that CBD may therefore provide a potential treatment to exert antidepressant-like effects through various molecular targets, reducing inflammation, and enhancing neurogenesis.
Conclusions
Taken together with the growing popularity of CBD as a medicine, these findings extend the limited knowledge on the antidepressant effects of CBD. This potentially opens up new therapeutic means for the patients with depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China.
- Department of Pharmacology, Jiangyin Hospital of Traditional Chinese Medicine, Jiangyin, Jiangsu, China.
- Department of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China.
ORCID-Profile: Wei Guan
Zitieren
APA
Miao, Y., Zhao, F., & Guan, W. (2025). A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae064
Vancouver
Miao Y, Zhao F, Guan W. A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyae064
BibTeX
@article{Miao2025,
author = {Miao, Yang and Zhao, Fei and Guan, Wei},
title = {A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors},
journal = {International Journal of Neuropsychopharmacology},
year = {2025},
doi = {10.1093/ijnp/pyae064}
}
EUVIMED